Skip to content
Study details
Enrolling now

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

Washington University School of Medicine
NCT IDNCT05831579ClinicalTrials.gov data as of Apr 2026
Target enrollment

20

Study length

about 4.1 years

Ages

18+

Locations

1 site in MO

About this study

This trial is testing a new way to deliver radiation therapy called Proton GRID radiotherapy for people with cancer that cannot be removed surgically. The goal is to see if this treatment approach is safe and effective in providing palliative care.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Receive Proton GRID Radiotherapy
Primary goalRate of treatment-related acute toxicity

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low12%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Rate of treatment-related acute toxicity, Rate of treatment-related late toxicity

Secondary: Change in PRO-CTCAE (General Inventory and Disease Specific Inventory Assessment), Change in PROMIS Global Health

Procedures

radiation

Body systems

Oncology